Qianjiang Yongan Pharmaceutical Co.,Ltd.’s Net Profit Dropped 73.5% in First Three Quarters of 2023

Qianjiang Yongan Pharmaceutical Co.,Ltd. (潜江永安药业股份有限公司) (002365.SZ) reported a net profit of 41.1 million yuan in the first three quarters of 2023, down 73.5% year-on-year.

Meanwhile, the company posted 802.8 million yuan in revenue, down 28.5% year-on-year.

At the end of the reporting period, it had 2.4 billion yuan in total assets and 306.6 million yuan in total liabilities, with a liability-to-asset ratio of 12.6%.